2-tert-butylhydroquinone has been researched along with Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhter, H; Katre, A; Li, L; Liu, RM; Liu, X | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Amyloidosis
| Article | Year |
|---|---|
Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Antioxidants; Blood-Brain Barrier; Blotting, Western; Brain Chemistry; Diet; Fibrinolysin; Glutathione; Humans; Hydroquinones; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxidative Stress; Plasminogen Activator Inhibitor 1; Presenilin-1; Urokinase-Type Plasminogen Activator | 2011 |